| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8714253 | The Journal of Allergy and Clinical Immunology: In Practice | 2018 | 16 Pages |
Abstract
This meta-analysis demonstrates that extrafine ICSs have significantly higher odds of achieving asthma control with lower exacerbation rates at significantly lower prescribed doses than fine-particle ICSs.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Samatha FRCPCH, PhD, Brett PhD, Dirkje S. MD, Richard J. MD, Nicolas MD, Jonathan MD, FRCPCH, Theresa MD, MS, Caroline MD, Emilio MD, Akio MD, PhD, Wanda MD, MS, Alison MSc, Ronald J. MD, Alan MD, Elliot MD, Alberto MD, Willem M.C. MD, Omar S. FRCP, PhD,